Developing and Testing a COVID-19 Vaccination Acceptance Intervention (CoVAcS)
COVID-19 Vaccination
About this trial
This is an interventional health services research trial for COVID-19 Vaccination focused on measuring COVID-19 Vaccine, Motivational Interviewing
Eligibility Criteria
Inclusion Criteria:
Inclusion Criteria by Aim:
- Aim 1: Primary care clinic visit in VISN 16 or 21
Aim 2: =1 visit(s) at a participating VISN 16 or 21 primary care clinic or CBOC after the start of the trial at their site, and at the time of recruitment, COVID-19 vaccination status is verified as one of the following:
- has not initiated COVID-19 vaccination
- has initiated one of the two mRNA vaccines and is outside the window for the second dose
- recently completed COVID-19 vaccination (has completed two doses of mRNA vaccination or has completed the single-dose Janssen/Johnson & Johnson vaccine within the past 60 days)
- Aim 3: Implementation-focused Interviews with VISN 16 and 21 Staff and HCPs
Exclusion Criteria:
Exclusion Criteria by Aim:
- Aim 1: Per VISN or VAMC leadership, the clinic or CBOC has extreme staffing shortages such that it would not be feasible or in the best interests of patient care to allow clinic or CBOC staff release time to participate in trainings or other meetings related to the trial
Aim 2: Has initiated COVID-19 vaccination with one of the mRNA vaccines and is within the window to complete the second dose on schedule (< 42 days since dose 1)
- Serious allergic reaction or other contraindication to COVID-19 vaccination or other vaccines (e.g., flu vaccine)
- Currently in hospice care or < 6 months to live
- No consistent ability to be contacted by phone
- Participating in another COVID-19 trial or study (research study flag)
- Moderate to severe dementia as documented in the patient's VA medical record
- Increased suicide risk as indicated by behavioral health flag
- Aim 3: Staff or HCPs declines invitation to participate in the interview
Sites / Locations
- Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
- San Francisco VA Medical Center, San Francisco, CA
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention Arm
Usual Care Arm
The VAMC Internal Facilitator will partner with the trial External Facilitators (research team and designated External Facilitators in VISNS 16 and 21) to adapt and implement the study intervention to best meet the needs and preferences of their VAMC site. In addition, each CBOC and clinic affiliated with a VAMC in the Intervention arm will need to identify a Site Champion to provide clinic-specific information to facilitate implementation of the Vaccine Acceptance Intervention at their clinic or CBOC. In addition, for clinics and CBOCs assigned to the Vaccine Acceptance Intervention, VAMC, clinic and CBOC leadership will need to agree to release PACT staff for an initial two-hour Motivational Interviewing (MI) training, and at least one 60-minute post-training consultation session over the one-year trial period. There will be additional consultation sessions offered to intervention clinics and CBOC staff, but these will be optional.
A VAMC assigned to Usual Care will have no specific trial intervention requirements beyond their usual level of participation in national and local initiatives to improve COVID-19 vaccine acceptance. At both Intervention and Usual Care sites, the study team will perform quarterly "environmental scans". The environmental scan survey will include questions about site specific barriers to COVID-19 vaccination (first dose and second dose if needed), current programs/initiatives in the clinic or local community that are improving or have had no impact on vaccination rates, and the perceived importance that the VAMC/CBOC clinic staff is placing on vaccination (Environmental Scan Survey, in preparation). At Usual Care sites, a point of contact will be chosen from each clinic and CBOC to complete the environmental scan, and at Intervention sites, the Site Champion (see below) will perform the quarterly scan.